梅花生物：上半年实现归母净利润17.7亿元，同比增长20%

Core Insights - The company reported a revenue of 12.28 billion yuan for the first half of 2025, a year-on-year decrease of 2.9% [2] - The net profit attributable to the parent company was 1.77 billion yuan, reflecting a year-on-year increase of 20.0% [2] Company Performance - The company is recognized as a leading player in the global amino acid industry, focusing on a diversified product matrix centered around amino acids, including animal nutrition amino acids, flavor enhancers, pharmaceutical amino acids, and colloidal polysaccharides [2] - Key products such as monosodium glutamate, 98% lysine, and feed-grade isoleucine saw an increase in sales volume during the reporting period [2] - The increase in revenue and gross profit was driven by a rise in both volume and price of 70% lysine, alongside a decrease in major material costs and improved production metrics, resulting in a gross profit increase of 382 million yuan [2]